FBXO6

UniProt ID: Q9NRD1
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

FBXO6 (FBG2/FBS2, F-box protein that recognizes sugar chains 2) is a 293-amino-acid cytoplasmic F-box protein and a member of the FBA (F-box-associated) lectin family (FBXO2/FBXO6/FBXO17/FBXO27/FBXO44). It serves as the substrate-recognition subunit of SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complexes: its N-terminal F-box domain docks onto SKP1 (and thence CUL1-RBX1), while its C-terminal FBA/G domain is a carbohydrate-binding lectin module that recognizes N-linked glycans on client proteins. As an F-box protein FBXO6 has no intrinsic catalytic activity; catalysis is contributed by the RING subunit RBX1 within the assembled SCF complex, and FBXO6 confers substrate specificity. Through its FBA domain FBXO6 binds high-mannose oligosaccharides (with the chitobiose core being essential), complex-type glycans, and sulfated glycoproteins, and it preferentially engages denatured/misfolded glycoproteins. This lectin activity directs misfolded glycoproteins that have been retrotranslocated to the cytosol into the endoplasmic-reticulum-associated degradation (ERAD)/glycoprotein-quality-control pathway, promoting their ubiquitination and proteasomal degradation. FBXO6 also has a documented role in the DNA replication/damage checkpoint: it recognizes activated, S345-phosphorylated CHEK1 (CHK1) via its FBA domain and assembles an SCF(FBXO6) complex that ubiquitinates CHK1 and targets it for degradation, contributing to checkpoint termination and influencing cellular sensitivity to replication stress. FBXO6 is broadly but variably expressed (notably in liver and kidney) and interacts with VCP/p97. Among its glycoprotein clients, SCF(FBXO6/Fbs2) ubiquitinates the ER-membrane transcription factor NFE2L1/NRF1; in the absence of the cytoplasmic deglycosylase NGLY1, FBXO6-mediated ubiquitination of still-glycosylated NFE2L1 impairs its processing and nuclear function, blunting the proteasome "bounce-back" induction of new proteasome subunits, and genetic reduction of Fbs2/FBXO6 partially rescues Ngly1-knockout phenotypes in mice (with Fbs2-knockout mice otherwise healthy).

Existing Annotations Review

GO Term Evidence Action Reason
GO:0036503 ERAD pathway
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment of involvement in ER-associated degradation, a core biological process of the FBA lectin family of F-box proteins.
Reason: Core biological process; FBXO6 recognizes glycans on misfolded glycoproteins to direct them to ERAD/proteasomal degradation, supported by UniProt and ISS.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Involved in endoplasmic reticulum-associated degradation pathway (ERAD) for misfolded lumenal proteins by recognizing and binding sugar chains on unfolded glycoproteins that are retrotranslocated into the cytosol and promoting their ubiquitination and subsequent degradation
GO:0005737 cytoplasm
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment of cytoplasmic localization, consistent with the documented cytoplasmic site of FBXO6 action.
Reason: Correct localization; SCF(FBXO6) acts in the cytosol on retrotranslocated glycoproteins and on cytoplasmic CHK1; supported by IDA (PMID:19716789) and UniProt subcellular location.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0006516 glycoprotein catabolic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment of involvement in glycoprotein catabolism, a core process for this lectin F-box family that targets glycoproteins for degradation.
Reason: Core biological process; FBXO6 recognizes glycans on misfolded glycoproteins and routes them to degradation.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
recognizing and binding sugar chains on unfolded glycoproteins that are retrotranslocated into the cytosol and promoting their ubiquitination and subsequent degradation
GO:0019005 SCF ubiquitin ligase complex
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment placing FBXO6 in the SCF (SKP1-CUL1-F-box) ubiquitin ligase complex, its defining structural context as an F-box protein.
Reason: Core cellular-complex assignment; FBXO6 assembles into a canonical SCF complex (SKP1, CUL1, RBX1) via its F-box domain, supported experimentally.
Supporting Evidence:
PMID:18203720
All FBA family members co-immunoprecipitated components of the SCF complex
GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment of involvement in SCF-dependent proteasomal degradation, the core biological process executed by SCF(FBXO6).
Reason: Core biological process; FBXO6 acts as the substrate receptor of an SCF complex that drives proteasomal degradation of its glycoprotein and CHK1 substrates.
Supporting Evidence:
PMID:19716789
an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase, which mediates the ubiquitination and degradation of Chk1
GO:0044322 endoplasmic reticulum quality control compartment
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic assignment to the ER quality-control compartment, inferred from the family's role in glycoprotein quality control/ERAD.
Reason: Plausible localization inferred from the ERAD/glycoprotein-QC role, but FBXO6 is a cytoplasmic protein that engages substrates after retrotranslocation; direct ERQC localization is not demonstrated for FBXO6.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
recognizing and binding sugar chains on unfolded glycoproteins that are retrotranslocated into the cytosol
GO:0061630 ubiquitin protein ligase activity
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic assignment of ubiquitin protein ligase activity with a contributes_to qualifier, reflecting that FBXO6 is the substrate receptor that contributes to the activity of the assembled SCF E3 ligase rather than carrying catalytic activity itself.
Reason: FBXO6 has no intrinsic catalytic ligase activity; catalysis resides in the RING subunit RBX1. The contributes_to qualifier is the correct way to capture that FBXO6 contributes substrate specificity to SCF ligase activity, but FBXO6's own core molecular function is carbohydrate binding, so this is retained as non-core rather than as the gene's primary function.
Supporting Evidence:
PMID:18203720
As the substrate recognition subunits of multiprotein ubiquitin ligase complexes, F-box proteins have no intrinsic catalytic activity of their own.
GO:0005737 cytoplasm
IEA
GO_REF:0000120
ACCEPT
Summary: Combined automated electronic assignment of cytoplasmic localization, consistent with the experimentally documented cytoplasmic site of FBXO6.
Reason: Correct localization; redundant with the IDA (PMID:19716789) and IBA cytoplasm annotations.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005515 protein binding
IPI
PMID:23108047
FBXW7-mediated degradation of CCDC6 is impaired by ATM durin...
KEEP AS NON CORE
Summary: IntAct interaction with CUL1 (Q13616), the cullin scaffold of the SCF complex. A real and functionally relevant interaction, but the bare protein binding term is uninformative.
Reason: Records the FBXO6-CUL1 SCF-assembly interaction, but bare protein binding is uninformative per curation guidelines; the SCF-complex membership is captured by GO:0019005.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Q9NRD1; Q13616: CUL1; NbExp=6; IntAct=EBI-3938499, EBI-359390
GO:0005515 protein binding
IPI
PMID:27705803
A High-Density Map for Navigating the Human Polycomb Complex...
KEEP AS NON CORE
Summary: IntAct interaction with SKP1 (P63208), the adaptor that bridges the F-box domain to CUL1. A real SCF-assembly interaction, but bare protein binding is uninformative.
Reason: Records the FBXO6-SKP1 interaction central to SCF assembly, but bare protein binding is uninformative; SCF membership is captured by GO:0019005.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Q9NRD1; P63208: SKP1; NbExp=10; IntAct=EBI-3938499, EBI-307486
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
KEEP AS NON CORE
Summary: High-throughput interactome interaction with CUL1 (Q13616). A real SCF-component interaction, but bare protein binding is uninformative.
Reason: Records the FBXO6-CUL1 interaction but bare protein binding is uninformative; captured at the complex level by GO:0019005.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Q9NRD1; Q13616: CUL1; NbExp=6; IntAct=EBI-3938499, EBI-359390
GO:0005515 protein binding
IPI
PMID:30833792
A protein-interaction network of interferon-stimulated genes...
KEEP AS NON CORE
Summary: Interferon-stimulated-gene interactome capturing FBXO6 interactions with SKP1 (P63208), CUL1 (Q13616) and LGALS3BP (Q08380, a secreted glycoprotein). Bare protein binding is uninformative.
Reason: Records SCF-component interactions plus a glycoprotein (LGALS3BP) interaction, but bare protein binding is uninformative; relevant functions are captured by the SCF-complex and carbohydrate-binding annotations.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Q9NRD1; Q08380: LGALS3BP; NbExp=2; IntAct=EBI-3938499, EBI-354956
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
KEEP AS NON CORE
Summary: Binary interactome reference map capturing the FBXO6-SKP1 (P63208) interaction. Bare protein binding is uninformative.
Reason: Records the FBXO6-SKP1 interaction but bare protein binding is uninformative; SCF membership is captured by GO:0019005.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Q9NRD1; P63208: SKP1; NbExp=10; IntAct=EBI-3938499, EBI-307486
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
KEEP AS NON CORE
Summary: Cell-specific interactome capturing FBXO6 interactions with SKP1 (P63208) and CUL1 (Q13616). Bare protein binding is uninformative.
Reason: Records SCF-component interactions but bare protein binding is uninformative; captured at the complex level by GO:0019005.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Q9NRD1; P63208: SKP1; NbExp=10; IntAct=EBI-3938499, EBI-307486
GO:0005515 protein binding
IPI
PMID:40205054
Multimodal cell maps as a foundation for structural and func...
KEEP AS NON CORE
Summary: Multimodal cell-map interactome capturing FBXO6 interactions with SKP1 (P63208) and CUL1 (Q13616). Bare protein binding is uninformative.
Reason: Records SCF-component interactions but bare protein binding is uninformative; captured at the complex level by GO:0019005.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Q9NRD1; Q13616: CUL1; NbExp=6; IntAct=EBI-3938499, EBI-359390
GO:0006511 ubiquitin-dependent protein catabolic process
IEA
GO_REF:0000107
ACCEPT
Summary: Ortholog-based electronic assignment of ubiquitin-dependent protein catabolism, a parent process consistent with FBXO6's role as an SCF substrate receptor.
Reason: Correct but generic; the more specific GO:0031146 (SCF-dependent proteasomal ubiquitin-dependent catabolism) and GO:0036503 (ERAD) better capture the core role.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
promoting their ubiquitination and subsequent degradation
GO:0019005 SCF ubiquitin ligase complex
IEA
GO_REF:0000107
ACCEPT
Summary: Ortholog-based electronic assignment of SCF complex membership, the defining context of FBXO6 as an F-box protein.
Reason: Core cellular-complex assignment; redundant with the IBA, NAS and IDA SCF-complex annotations and experimentally supported.
Supporting Evidence:
PMID:18203720
All FBA family members co-immunoprecipitated components of the SCF complex
GO:0030246 carbohydrate binding
IEA
GO_REF:0000107
ACCEPT
Summary: Ortholog-based electronic assignment of carbohydrate binding, capturing the FBA/G-domain lectin activity that is the core molecular function distinguishing this F-box subfamily.
Reason: Core molecular function; the FBA domain is a lectin that binds high-mannose, complex and sulfated glycans, directly demonstrated by glycan-array and pulldown assays.
Supporting Evidence:
PMID:18203720
FBXO6 bound high mannose glycans with relatively high affinity
GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
IEA
GO_REF:0000107
ACCEPT
Summary: Ortholog-based electronic assignment of SCF-dependent proteasomal degradation, the core process executed by SCF(FBXO6).
Reason: Core biological process; redundant with the IBA, NAS and IDA annotations of the same term.
Supporting Evidence:
PMID:19716789
an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase, which mediates the ubiquitination and degradation of Chk1
GO:0036503 ERAD pathway
IEA
GO_REF:0000107
ACCEPT
Summary: Ortholog-based electronic assignment of involvement in ERAD, a core biological process for FBXO6.
Reason: Core biological process; redundant with the IBA and ISS ERAD annotations.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Involved in endoplasmic reticulum-associated degradation pathway (ERAD) for misfolded lumenal proteins
GO:0044322 endoplasmic reticulum quality control compartment
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Ortholog-based electronic assignment to the ER quality-control compartment, inferred from the glycoprotein-QC/ERAD role.
Reason: Plausible but not directly demonstrated for FBXO6, which is a cytoplasmic protein engaging substrates after retrotranslocation; the experimentally supported localization is cytoplasm.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0061630 ubiquitin protein ligase activity
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Ortholog-based electronic assignment of ubiquitin protein ligase activity with a contributes_to qualifier, reflecting FBXO6's contribution of substrate specificity to the SCF E3 ligase.
Reason: FBXO6 has no intrinsic catalytic ligase activity (RBX1 is catalytic); the contributes_to qualifier correctly conveys that FBXO6 contributes substrate recognition to SCF ligase activity, but the gene's own core molecular function is carbohydrate binding.
Supporting Evidence:
PMID:18203720
As the substrate recognition subunits of multiprotein ubiquitin ligase complexes, F-box proteins have no intrinsic catalytic activity of their own.
GO:0016567 protein ubiquitination
IEA
GO_REF:0000041
KEEP AS NON CORE
Summary: UniPathway-derived general protein ubiquitination process, a parent of the specific SCF-dependent ubiquitination FBXO6 contributes to.
Reason: Correct but generic; the specific SCF-dependent proteasomal catabolism and ERAD annotations better capture FBXO6's role.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
PATHWAY: Protein modification; protein ubiquitination.
GO:0019005 SCF ubiquitin ligase complex
NAS
PMID:34445249
The SCF Complex Is Essential to Maintain Genome and Chromoso...
ACCEPT
Summary: ComplexPortal/Reactome non-traceable author statement placing FBXO6 in an SCF E3 ubiquitin ligase complex; consistent with a defined ComplexPortal entry (CPX-7905, SCF FBXO6 variant).
Reason: Core cellular-complex assignment; FBXO6 is a defined F-box substrate-receptor variant of the SCF complex, supported experimentally (PMID:18203720) and by ComplexPortal CPX-7905.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
ComplexPortal; CPX-7905; SCF E3 ubiquitin ligase complex, FBXO6 variant.
GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
NAS
PMID:34445249
The SCF Complex Is Essential to Maintain Genome and Chromoso...
ACCEPT
Summary: ComplexPortal non-traceable author statement of involvement in SCF-dependent proteasomal degradation, the core process of SCF complexes including SCF(FBXO6).
Reason: Core biological process; redundant with the IBA, IEA and IDA annotations of the same term.
Supporting Evidence:
PMID:34445249
SCF E3 ubiquitin ligase complexes that primarily modify protein substrates with poly-ubiquitin chains to target them for proteasomal degradation
GO:0005829 cytosol
TAS
Reactome:R-HSA-8952618
ACCEPT
Summary: Reactome curation of cytosolic localization within a CRL1/neddylation reaction (NEDD8 transfer to CRL1). Consistent with the cytoplasmic localization of FBXO6 and its SCF complex.
Reason: Correct localization; the cytosol is a child of cytoplasm and consistent with the experimentally supported cytoplasmic localization; these Reactome cytosol annotations reflect generic CRL/neddylation machinery reactions.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005829 cytosol
TAS
Reactome:R-HSA-8952620
ACCEPT
Summary: Reactome curation of cytosolic localization within a CRL1/neddylation reaction. Consistent with FBXO6's cytoplasmic localization.
Reason: Correct localization (cytosol is part of cytoplasm); reflects generic CRL/neddylation reactions and is redundant with the experimentally supported cytoplasm annotation.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005829 cytosol
TAS
Reactome:R-HSA-8955241
ACCEPT
Summary: Reactome curation of cytosolic localization (CAND1 binds cytosolic CRL E3 ligases). Consistent with FBXO6's cytoplasmic localization.
Reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic CRL-regulation machinery reactions.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005829 cytosol
TAS
Reactome:R-HSA-8955289
ACCEPT
Summary: Reactome curation of cytosolic localization (COMMDs displace CAND1 from cytosolic CRL complexes). Consistent with FBXO6's cytoplasmic localization.
Reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic CRL-regulation machinery reactions.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005829 cytosol
TAS
Reactome:R-HSA-8956040
ACCEPT
Summary: Reactome curation of cytosolic localization (COP9 signalosome deneddylates cytosolic CRL complexes). Consistent with FBXO6's cytoplasmic localization.
Reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic CRL-regulation machinery reactions.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005829 cytosol
TAS
Reactome:R-HSA-8956200
ACCEPT
Summary: Reactome curation of cytosolic localization (MyrG-DCUN1D3 binds CRL1 complex). Consistent with FBXO6's cytoplasmic localization.
Reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic CRL-regulation machinery reactions.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005829 cytosol
TAS
Reactome:R-HSA-983140
ACCEPT
Summary: Reactome curation of cytosolic localization within a generic ubiquitination reaction (transfer of Ub from E2 to substrate). Consistent with FBXO6's cytoplasmic localization.
Reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic SCF ubiquitination-reaction machinery.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005829 cytosol
TAS
Reactome:R-HSA-983147
ACCEPT
Summary: Reactome curation of cytosolic localization within a generic ubiquitination reaction (release of E3 from polyubiquitinated substrate). Consistent with FBXO6's cytoplasmic localization.
Reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic SCF ubiquitination-reaction machinery.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005829 cytosol
TAS
Reactome:R-HSA-983156
ACCEPT
Summary: Reactome curation of cytosolic localization within a generic ubiquitination reaction (polyubiquitination of substrate). Consistent with FBXO6's cytoplasmic localization.
Reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic SCF ubiquitination-reaction machinery.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0005829 cytosol
TAS
Reactome:R-HSA-983157
ACCEPT
Summary: Reactome curation of cytosolic localization within a generic ubiquitination reaction (interaction of E3 with substrate and E2-Ub complex). Consistent with FBXO6's cytoplasmic localization.
Reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic SCF ubiquitination-reaction machinery.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}
GO:0000077 DNA damage checkpoint signaling
TAS
PMID:19716789
The F box protein Fbx6 regulates Chk1 stability and cellular...
KEEP AS NON CORE
Summary: Traceable author statement linking FBXO6 to the DNA damage/replication checkpoint via SCF(FBXO6)-mediated ubiquitination and degradation of activated CHK1, which terminates the checkpoint.
Reason: Well-supported, genuine role (degradation of activated CHK1 contributes to checkpoint termination), but distinct from the gene's primary glycan-recognition/ERAD core function; retained as a non-core second process.
Supporting Evidence:
PMID:19716789
DNA damage not only activates Chk1, but also exposes a degron-like region at the carboxyl terminus of Chk1 to an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase, which mediates the ubiquitination and degradation of Chk1 and, in turn, terminates the checkpoint
GO:0005515 protein binding
IPI
PMID:19716789
The F box protein Fbx6 regulates Chk1 stability and cellular...
KEEP AS NON CORE
Summary: IPI interaction with CHEK1/CHK1 (O14757), a functionally important FBXO6 substrate engaged via the FBA domain. Bare protein binding is uninformative.
Reason: Records the functionally meaningful FBXO6-CHK1 substrate interaction, but bare protein binding is uninformative; the CHK1-regulation role is captured by the checkpoint/SCF-catabolism annotations.
Supporting Evidence:
PMID:19716789
endogenous Fbx6 was co-immunoprecipitated with Chk1 in extracts from non-transfected cells
GO:0005737 cytoplasm
IDA
PMID:19716789
The F box protein Fbx6 regulates Chk1 stability and cellular...
ACCEPT
Summary: Direct experimental evidence (immunolocalization) that FBXO6 is mainly localized to the cytoplasm, where it engages CHK1.
Reason: Core localization with direct experimental support; FBXO6 acts in the cytoplasm/cytosol on its substrates.
Supporting Evidence:
PMID:19716789
The Fbx6-Chk1 interaction was only detected in the cytoplasmic compartment where Fbx6 is mainly localized
GO:0006281 DNA repair
TAS
PMID:19716789
The F box protein Fbx6 regulates Chk1 stability and cellular...
MARK AS OVER ANNOTATED
Summary: Traceable author statement annotating FBXO6 to DNA repair, derived from its role in the ATR-CHK1 replication-checkpoint pathway that coordinates DNA damage/repair responses.
Reason: FBXO6's documented role is checkpoint termination via CHK1 degradation, not DNA repair per se; CHK1 activation triggers repair responses, but FBXO6 acts to remove activated CHK1 and is not itself a repair factor. DNA damage checkpoint signaling (GO:0000077) more accurately captures the role; DNA repair is an over-annotation of the downstream pathway.
Supporting Evidence:
PMID:19716789
which mediates the ubiquitination and degradation of Chk1 and, in turn, terminates the checkpoint
GO:0019005 SCF ubiquitin ligase complex
IDA
PMID:19716789
The F box protein Fbx6 regulates Chk1 stability and cellular...
ACCEPT
Summary: Direct experimental evidence that FBXO6 forms an SCF (SKP1-CUL1-FBXO6) complex, demonstrated by co-immunoprecipitation of SCF components.
Reason: Core cellular-complex assignment with direct experimental support.
Supporting Evidence:
PMID:19716789
an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase
GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
IDA
PMID:19716789
The F box protein Fbx6 regulates Chk1 stability and cellular...
ACCEPT
Summary: Direct experimental evidence that SCF(FBXO6) drives the ubiquitination and proteasomal degradation of CHK1, demonstrating involvement in SCF-dependent proteasomal catabolism.
Reason: Core biological process with direct experimental (IDA) support; FBXO6 FL supported CHK1 ubiquitination in vitro and FBXO6 depletion stabilized CHK1.
Supporting Evidence:
PMID:19716789
only the Fbx6 FL protein supported ubiquitination of Chk1 in vitro
GO:0036503 ERAD pathway
ISS
GO_REF:0000024
ACCEPT
Summary: Sequence-similarity-based assignment of involvement in ERAD, transferred from the mouse ortholog (Q9QZN4); a core biological process.
Reason: Core biological process; consistent with the IBA and IEA ERAD annotations and the documented glycan-recognition/glycoprotein-degradation function.
Supporting Evidence:
file:human/FBXO6/FBXO6-uniprot.txt
Involved in endoplasmic reticulum-associated degradation pathway (ERAD) for misfolded lumenal proteins
GO:0006508 proteolysis
TAS
PMID:10531035
Identification of a family of human F-box proteins.
KEEP AS NON CORE
Summary: Early traceable author statement (F-box family identification paper) annotating FBXO6 to proteolysis, reflecting the general role of F-box proteins in SCF-mediated protein degradation.
Reason: Correct but very generic; the specific SCF-dependent proteasomal catabolism and ERAD annotations better capture FBXO6's role. The abstract describes the F-box family broadly rather than FBXO6 specifically.
Supporting Evidence:
PMID:10531035
F-box proteins are one of the four subunits of ubiquitin protein ligases called SCFs

Core Functions

Carbohydrate-binding (lectin) substrate-recognition subunit of an SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase; via its FBA/G domain FBXO6 binds N-linked high-mannose and complex/sulfated glycans on misfolded glycoproteins and, as part of the SCF complex, directs them to ubiquitination and proteasomal degradation in the glycoprotein-quality-control/ERAD pathway.

Molecular Function:
carbohydrate binding
Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • PMID:18203720
    FBXO6 bound high mannose glycans with relatively high affinity
  • file:human/FBXO6/FBXO6-uniprot.txt
    recognizing and binding sugar chains on unfolded glycoproteins that are retrotranslocated into the cytosol and promoting their ubiquitination and subsequent degradation
  • file:human/FBXO6/FBXO6-deep-research-falcon.md
    ERAD glycoprotein substrates (including the transcription factor **NFE2L1/NRF1**) are ubiquitinated by multiple E3 ligases, including **SCF^FBS2**, and then degraded by the proteasome; in typical conditions, many ubiquitinated glycoproteins are thought to be **deglycosylated by NGLY1 during proteasomal degradation**.

Substrate receptor of an SCF(FBXO6) E3 ligase that recognizes activated, S345-phosphorylated CHEK1/CHK1 through its FBA domain and targets it for ubiquitination and proteasomal degradation, contributing to termination of the DNA replication/damage checkpoint and modulating cellular sensitivity to replication stress.

Molecular Function:
carbohydrate binding
Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • PMID:19716789
    an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase, which mediates the ubiquitination and degradation of Chk1 and, in turn, terminates the checkpoint

References

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniPathway vocabulary mapping
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
Identification of a family of human F-box proteins.
  • FBXO6 was identified as one of a family of 26 human F-box proteins; F-box proteins are substrate-recognition subunits of SCF ubiquitin ligases.
Diversity in tissue expression, substrate binding, and SCF complex formation for a lectin family of ubiquitin ligases.
  • FBXO6 is a member of the FBA lectin family whose conserved G/FBA domain binds high-mannose, complex and sulfated glycans (chitobiose core essential); a Y241/W242 hydrophobic pocket is required for glycan binding, and FBXO6 co-precipitates SCF components (SKP1, CUL1, RBX1). F-box proteins have no intrinsic catalytic activity.
The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.
  • FBXO6 (Fbx6) is the substrate-recognition subunit of an SCF (SKP1-CUL1-FBXO6) E3 ligase that, via its FBA domain, binds activated CHK1 and mediates CHK1 ubiquitination and degradation to terminate the replication checkpoint; FBXO6 is mainly cytoplasmic and its level inversely correlates with CHK1 and modulates camptothecin sensitivity.
FBXW7-mediated degradation of CCDC6 is impaired by ATM during DNA damage response in lung cancer cells.
A High-Density Map for Navigating the Human Polycomb Complexome.
Architecture of the human interactome defines protein communities and disease networks.
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.
A reference map of the human binary protein interactome.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
The SCF Complex Is Essential to Maintain Genome and Chromosome Stability.
  • The SCF complex comprises ~69 SCF E3 ubiquitin ligase complexes distinguished by variable F-box proteins that determine substrate specificity and target substrates for proteasomal degradation.
Multimodal cell maps as a foundation for structural and functional genomics.
Reactome:R-HSA-8952618
AcM-UBE2M transfers NEDD8 to CRL1 E3 ubiquitin ligase complex
Reactome:R-HSA-8952620
NEDD8:AcM-UBE2M binds CRL1 E3 ubiquitin ligase complex
Reactome:R-HSA-8955241
CAND1 binds cytosolic CRL E3 ubiquitin ligases
Reactome:R-HSA-8955289
COMMDs displace CAND1 from cytosolic CRL E3 ubiquitin ligase complexes
Reactome:R-HSA-8956040
COP9 signalosome deneddylates cytosolic CRL E3 ubiquitin ligase complexes
Reactome:R-HSA-8956200
MyrG-DCUN1D3 binds CRL1 E3 ubiquitin ligase complex
Reactome:R-HSA-983140
Transfer of Ub from E2 to substrate and release of E2
Reactome:R-HSA-983147
Release of E3 from polyubiquitinated substrate
Reactome:R-HSA-983156
Polyubiquitination of substrate
Reactome:R-HSA-983157
Interaction of E3 with substrate and E2-Ub complex
file:human/FBXO6/FBXO6-deep-research-falcon.md
Falcon deep research report for human FBXO6
  • FBXO6 (FBS2) is the substrate-recognition module of an SCF-type (SCF^FBS2 / SCF^FBXO6) ubiquitin ligase that ubiquitinates N-glycoprotein substrates in protein quality control.
    "FBXO6 (FBS2) is discussed as an F-box protein that serves as the substrate-recognition module of an SCF-type ubiquitin ligase (**SCF^FBS2 / SCF^FBXO6**), enabling ubiquitination of selected substrates, including **N-glycoproteins** involved in protein quality control."
  • In the NGLY1/ERAD axis, SCF^FBS2 ubiquitinates ERAD glycoprotein substrates including the transcription factor NFE2L1/NRF1, which are then degraded by the proteasome after deglycosylation by NGLY1.
    "ERAD glycoprotein substrates (including the transcription factor **NFE2L1/NRF1**) are ubiquitinated by multiple E3 ligases, including **SCF^FBS2**, and then degraded by the proteasome; in typical conditions, many ubiquitinated glycoproteins are thought to be **deglycosylated by NGLY1 during proteasomal degradation**."
  • When NGLY1 is absent, SCF^FBS2-mediated ubiquitination of NFE2L1 impairs its processing/nuclear function and blocks induction of proteasome subunits (the proteasome bounce-back response), contributing to proteasome dysfunction.
    "in the **absence of NGLY1**, SCF^FBS2-mediated ubiquitination of NFE2L1 is linked to impaired NFE2L1 processing/nuclear function and failure to induce proteasome subunits, contributing to chronic proteasome compromise and cytotoxicity."
  • SCF^FBS2 acts in the cytosolic/proteasomal arm of ERAD after retrotranslocation; ubiquitinated N-glycoproteins accumulate in the cytosol when NGLY1 is absent.
    "The mechanistic model places SCF^FBS2 activity in the **cytosolic/proteasomal degradation pathway for ERAD substrates** (i.e., after retrotranslocation from the ER lumen), and describes **accumulation of SCF^FBS2-ubiquitinated N-glycoproteins in the cytosol** when NGLY1 is absent."
  • Genetic reduction of Fbs2/FBXO6 partially rescues Ngly1-knockout lethality in mice, and Fbs2-knockout mice are otherwise healthy, motivating FBS2 inhibition as a therapeutic concept for NGLY1 deficiency.
    "genetic reduction of FBS2/FBXO6** can partially rescue lethality/phenotypes associated with **Ngly1 knockout**, and that **Fbs2 knockout mice are reported as healthy** in that review context."

Suggested Questions for Experts

Q: Does FBXO6 recognize the CHK1 degron purely through a protein-protein (FBA-domain) interaction, or is glycan recognition also involved, and is the glycan-binding pocket (Y241/W242) dispensable for CHK1 targeting?

Q: What is the endogenous repertoire of glycoprotein substrates degraded specifically via SCF(FBXO6) (versus the paralog FBXO2), and how does FBXO6's broader specificity for complex and sulfated glycans translate into distinct in vivo substrates?

Q: How is partitioning between FBXO6's glycoprotein-ERAD role and its CHK1-checkpoint role regulated, and does the FBXO6-VCP/p97 interaction couple substrate recognition to retrotranslocation?

Q: Does SCF(FBXO6) ubiquitination of NFE2L1/NRF1 depend on the glycan-binding (FBA lectin) pocket, and is the proteasome bounce-back defect in NGLY1 deficiency driven specifically by FBXO6-mediated targeting of still-glycosylated NFE2L1?

Suggested Experiments

Experiment: Perform quantitative ubiquitinome/proteome profiling in FBXO6-knockout versus wild-type cells, with and without ER stress and replication stress (e.g. camptothecin), to define the endogenous SCF(FBXO6) substrate repertoire and distinguish glycoprotein from CHK1-dependent effects.

Experiment: Reconstitute SCF(FBXO6) ubiquitination in vitro with purified SKP1, CUL1, RBX1, an E2 and FBXO6, comparing wild-type FBXO6 with the Y241A/W242A glycan-pocket mutant against a high-mannose glycoprotein substrate and against phospho-CHK1 to dissect glycan-dependent versus glycan-independent substrate targeting.

Experiment: Use glycan-array and structural (crystallography/cryo-EM) analysis of the FBXO6 FBA domain bound to defined oligosaccharides to map the determinants of its broader specificity (high-mannose, complex, sulfated glycans) relative to FBXO2.

Deep Research

Falcon

(FBXO6-deep-research-falcon.md)
Research Report: Functional Annotation of Human **FBXO6** (UniProt **Q9NRD1**; synonyms **FBS2/FBG2/FBX6**) Falcon Edison Scientific Literature 17 citations 1 artifacts 2026-06-13T06:18:33.688681

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research Report: Functional Annotation of Human FBXO6 (UniProt Q9NRD1; synonyms FBS2/FBG2/FBX6)

0) Gene/protein identity verification (critical)

The literature retrieved in this run consistently treats FBS2 as the official gene/protein name FBXO6 and describes it as an F-box protein that recognizes sugar chains and functions within an SCF (SKP1–CUL1–F-box) E3 ubiquitin ligase context, matching the UniProt identity for human FBXO6/Q9NRD1 (F-box domain plus sugar-binding/galactose-binding-like superfamily features). (fujihira2022physiologicalimportanceof pages 4-5, fujihira2022physiologicalimportanceof pages 9-10)

1) Key concepts and definitions (current understanding)

1.1 FBXO6 as an SCF E3 ligase substrate receptor

FBXO6 (FBS2) is discussed as an F-box protein that serves as the substrate-recognition module of an SCF-type ubiquitin ligase (SCF^FBS2 / SCF^FBXO6), enabling ubiquitination of selected substrates, including N-glycoproteins involved in protein quality control. (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)

1.2 FBXO6 in ER-associated degradation (ERAD) and glycoproteostasis

ER-associated degradation (ERAD) eliminates misfolded secretory-pathway proteins, often glycoproteins, by retrotranslocation to the cytosol, ubiquitination, and proteasomal degradation. In the NGLY1/ERAD axis summarized in a 2022 review, ERAD glycoprotein substrates (including the transcription factor NFE2L1/NRF1) are ubiquitinated by multiple E3 ligases, including SCF^FBS2, and then degraded by the proteasome; in typical conditions, many ubiquitinated glycoproteins are thought to be deglycosylated by NGLY1 during proteasomal degradation. (fujihira2022physiologicalimportanceof pages 28-29)

1.3 Relationship to NGLY1 deficiency and proteasome homeostasis

NFE2L1 is central to the β€œproteasome bounce-back response” (induction of proteasome subunits under proteotoxic stress). In the cited mechanistic model, SCF^FBS2 ubiquitinates NFE2L1, and in the absence of NGLY1, SCF^FBS2-mediated ubiquitination of NFE2L1 is linked to impaired NFE2L1 processing/nuclear function and failure to induce proteasome subunits, contributing to chronic proteasome compromise and cytotoxicity. (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)

2) Molecular function, specificity, partners, localization (evidence-based)

2.1 Molecular function: ubiquitination (E3 ligase adaptor/substrate receptor)

Across the mechanistic sources retrieved here, the primary experimentally anchored molecular role for FBXO6 is as part of SCF^FBS2 that mediates ubiquitination of N-glycoprotein substrates (including NFE2L1 in the NGLY1-deficiency context). (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)

2.2 Substrate scope supported in retrieved evidence

The most specific substrate explicitly discussed in the retrieved evidence is NFE2L1, described as ubiquitinated by SCF^FBS2 and functionally impacted in NGLY1-deficient states. (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)

The same review framing also refers broadly to β€œERAD substrate glycoproteins” being ubiquitinated by SCF^FBS2, without naming additional specific protein substrates in the excerpts available here. (fujihira2022physiologicalimportanceof pages 28-29)

2.3 Sugar-chain recognition / lectin-like specificity

Within the full text inspected, FBXO6/FBS2 is repeatedly described at a high level as β€œan F-box protein that recognizes sugar chains”, consistent with UniProt’s alternative name β€œF-box protein that recognizes sugar chains 2.” (fujihira2022physiologicalimportanceof pages 4-5)

However, in the tool-retrieved excerpts available for this run, detailed biochemical specificity (e.g., high-mannose vs other N-glycan structures), structural determinants, and exact domain-function mapping (e.g., which residues mediate glycan binding) are not provided. (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)

2.4 Cellular localization and site of action

The mechanistic model places SCF^FBS2 activity in the cytosolic/proteasomal degradation pathway for ERAD substrates (i.e., after retrotranslocation from the ER lumen), and describes accumulation of SCF^FBS2-ubiquitinated N-glycoproteins in the cytosol when NGLY1 is absent. (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)

The excerpts retrieved here do not provide direct microscopy-based subcellular localization of FBXO6 itself (e.g., ER membrane association vs cytosolic distribution) or compartment-specific enrichment; thus, localization is inferred from the ERAD/proteasome context discussed rather than directly demonstrated in the excerpts available in this run. (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)

3) Recent developments (prioritizing 2023–2024)

3.1 2023: FBXO6 included in an ER-stress prognostic signature in breast cancer (TCGA-BRCA)

A 2023 study in Frontiers in Oncology (published May 2023) developed and validated an endoplasmic reticulum stress-related prognostic model (β€œERScore”) for breast cancer. In that work, FBXO6 was one of four genes (FBXO6, PMAIP1, ERP27, CHAC1) identified by multivariate Cox analysis as independent prognostic factors. (fan2023developmentandvalidation pages 1-2)

The authors also performed protein-level validation by Western blot, reporting that FBXO6 protein expression was higher in breast cancer cell lines (SKBR-3, MDA-MB-231, T-47D) than in the normal mammary epithelial line MCF-10A; they further report that FBXO6 expression did not significantly differ with breast cancer stage. Publication URL: https://doi.org/10.3389/fonc.2023.1178595 (fan2023developmentandvalidation pages 3-5, fan2023developmentandvalidation pages 17-18)

Quantitative data reported in the retrieved excerpts: the study evaluated drug sensitivity differences and found that 43 of 138 drugs showed significant differences between the high- and low-ERScore groups (and noted greater sensitivity to 8 drugs in the low-ERScore group). These are ERScore-level statistics rather than FBXO6-specific effect sizes. (fan2023developmentandvalidation pages 10-11)

3.2 2024: FBXO6 included in an FBXO-family prognostic model in hepatocellular carcinoma (HCC)

A 2024 paper in Journal of Cancer Research and Clinical Oncology (published Oct 2024) built a six-gene prognostic model for HCC from FBXO family members (FBXO5, FBXO6, FBXO16, FBXO30, FBXO32, FBXO45). Publication URL: https://doi.org/10.1007/s00432-024-05948-3 (gong2024fbxofamilygenes pages 11-14, gong2024fbxofamilygenes pages 7-11)

Key quantitative performance statistics reported: ROC AUC values for the model were 0.744, 0.670, and 0.638 at 1, 3, and 5 years, respectively. (gong2024fbxofamilygenes pages 11-14)

Experimental validation reported: the study used immunohistochemistry (IHC) and states that model genes (including FBXO6) showed higher expression in tumor vs adjacent tissue, including mention of higher expression of FBXO6 in invasive tumor specimens. (gong2024fbxofamilygenes pages 11-14)

Important limitation/expert-style interpretation: despite framing around p53 ubiquitination, the paper explicitly acknowledges that it did not elucidate specific molecular mechanisms of FBXO proteins in HCC and that lack of experimental verification is a limitation; the p53 connection for FBXO6 in this paper is primarily supported by bioinformatic prediction/docking rather than direct ubiquitination assays. (gong2024fbxofamilygenes pages 16-17)

4) Current applications and real-world implementations

4.1 Translational concept: FBXO6 inhibition as a potential strategy in NGLY1 deficiency (preclinical rationale)

Rodent model synthesis indicates that genetic reduction of FBS2/FBXO6 can partially rescue lethality/phenotypes associated with Ngly1 knockout, and that Fbs2 knockout mice are reported as healthy in that review context. This leads the authors to propose that FBS2 inhibition might be a promising therapeutic concept with potentially low side effects for NGLY1 deficiency (an ultra-rare congenital disorder of deglycosylation). (fujihira2022physiologicalimportanceof pages 9-10)

This is not a clinical implementation; rather, it represents a mechanistically motivated preclinical target rationale grounded in mouse genetics and proteostasis pathway logic. (fujihira2022physiologicalimportanceof pages 9-10)

4.2 Oncology: biomarker/model-gene usage in prognostic signatures

Two recent studies implement FBXO6 as a component of computational/omics-driven prognostic models:
- Breast cancer ER stress ERScore model with Western blot validation in cell lines (May 2023). (fan2023developmentandvalidation pages 1-2, fan2023developmentandvalidation pages 3-5)
- HCC FBXO-family model with IHC expression validation and time-dependent AUCs (Oct 2024). (gong2024fbxofamilygenes pages 11-14)

These implementations are β€œreal-world” in the sense of research/clinical bioinformatics workflows, but they are not yet established clinical tests.

5) Expert opinions and authoritative analysis (from retrieved sources)

5.1 Proteostasis-centered interpretation (review-level synthesis)

The NGLY1 rodent model review highlights a mechanistic link between SCF^FBS2-mediated ubiquitination of glycoproteins (including NFE2L1) and proteasome dysfunction in NGLY1-deficient settings, framing FBXO6/FBS2 as a meaningful node connecting ERAD substrate handling, deglycosylation status, and proteasome homeostatic responses. (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)

5.2 Caution on disease-mechanism claims from association studies

The 2024 HCC prognostic-model paper’s own text explicitly flags missing experimental verification of proposed mechanisms (including p53-related ubiquitination), underscoring that some FBXO6 disease-mechanism claims in cancer contexts remain hypothesis-generating rather than definitive. (gong2024fbxofamilygenes pages 16-17)

6) Relevant statistics and data (from recent studies)

  • Breast cancer (Frontiers in Oncology, May 2023): drug-sensitivity comparison between ERScore strata reported 43/138 drugs with significant differences (ERScore-level statistic). URL: https://doi.org/10.3389/fonc.2023.1178595 (fan2023developmentandvalidation pages 10-11)
  • HCC (J Cancer Res Clin Oncol, Oct 2024): six-gene prognostic model time-dependent ROC AUCs of 0.744 (1y), 0.670 (3y), 0.638 (5y). URL: https://doi.org/10.1007/s00432-024-05948-3 (gong2024fbxofamilygenes pages 11-14)
  • NGLY1 deficiency modifier genetics (reviewed, Sep 2022): 50% genetic reduction of FBS2 reported to partially rescue Ngly1-KO lethality; Fbs2-KO mice described as healthy in that synthesis. URL: https://doi.org/10.1093/jb/mvab101 (fujihira2022physiologicalimportanceof pages 9-10)

7) Summary of evidence-backed functional annotation

Functional aspect Key findings Evidence type System/Context Citation ID(s)
SCF substrate receptor in glycoprotein quality control FBXO6/FBS2 is described as part of an SCF ubiquitin ligase that ubiquitinates N-glycoproteins and participates in glycoprotein quality control linked to ER-associated degradation. Review synthesis of prior biochemical/cell studies NGLY1/ERAD pathway (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)
ERAD glycoprotein ubiquitination In NGLY1-deficient settings, SCF^FBS2-ubiquitinated N-glycoproteins accumulate in the cytosol and are associated with impaired proteasomal activity. Cell-based observations summarized in review NGLY1-deficient cells/models (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)
NFE2L1 regulation SCF^FBS2 ubiquitinates NFE2L1; in the absence of NGLY1 this impairs NFE2L1 processing/nuclear function and blocks proteasome subunit upregulation under proteotoxic stress. Review synthesis of mechanistic and cell-based findings NGLY1 deficiency and proteasome bounce-back pathway (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)
Genetic modifier of NGLY1 deficiency Reducing FBS2 dosage partially rescues lethality in Ngly1-knockout mice; Fbs2 deletion reportedly suppresses Ngly1-KO phenotypes more strongly than Engase deletion, while Fbs2-KO mice are described as otherwise healthy. Mouse genetics Rodent NGLY1-deficiency models (fujihira2022physiologicalimportanceof pages 9-10)
Candidate therapeutic target Because FBS2 loss is phenotypically tolerated in mice and alleviates Ngly1-deficiency phenotypes, reviews suggest FBS2 inhibition as a potential therapeutic strategy for NGLY1 deficiency. Expert review/analysis grounded in mouse genetics Translational interpretation of NGLY1-deficiency models (fujihira2022physiologicalimportanceof pages 9-10)
Breast cancer prognostic marker FBXO6 was one of four independent prognostic factors in an ER stress-related breast cancer model; protein expression was higher in breast cancer cell lines than in MCF-10A by Western blot, and FBXO6 expression reportedly did not significantly vary by stage. Bioinformatics + Western blot TCGA-BRCA ERScore model; SKBR-3, MDA-MB-231, T-47D vs MCF-10A (fan2023developmentandvalidation pages 1-2, fan2023developmentandvalidation pages 3-5, fan2023developmentandvalidation pages 17-18)
HCC prognostic/model gene FBXO6 was included in a six-gene FBXO-family prognostic model for HCC; IHC showed higher expression of model genes in tumor vs adjacent tissue, including higher FBXO6 in invasive tumor specimens. Model AUCs were 0.744, 0.670, and 0.638 at 1, 3, and 5 years. Bioinformatics + IHC TCGA-LIHC prognostic model (gong2024fbxofamilygenes pages 11-14, gong2024fbxofamilygenes pages 7-11, gong2024fbxofamilygenes pages 2-4)
HCC mechanism claims in literature vs current paper The 2024 HCC study cites prior literature that FBXO6 promotes degradation of NLRX1 and Chk1, but its own FBXO6-related mechanistic claims are mainly predictive/associative (e.g., p53 docking/prediction) and the authors acknowledge lack of direct experimental validation. Literature citation within paper + bioinformatics/IHC in current paper HCC (gong2024fbxofamilygenes pages 11-14, gong2024fbxofamilygenes pages 7-11, gong2024fbxofamilygenes pages 16-17)

Table: This table summarizes the directly supported functional annotation evidence retrieved for human FBXO6/Q9NRD1, separating mechanistic ERAD/NGLY1 findings from more associative cancer biomarker studies. It is useful for distinguishing well-supported core biology from newer, less validated disease-context observations.

8) Evidence gaps and what could not be confirmed from retrieved full text

  1. Precise glycan-binding specificity (e.g., defined N-glycan motifs) and structural mechanism of sugar recognition by FBXO6 were not available in the retrieved excerpts; therefore, this report does not claim a specific glycan preference beyond β€œrecognizes sugar chains.” (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)
  2. Direct subcellular localization data (immunofluorescence/biochemical fractionation of FBXO6) were not retrieved in the available text excerpts; localization is inferred from ERAD/proteasomal context. (fujihira2022physiologicalimportanceof pages 9-10)
  3. Cancer-mechanism details for FBXO6 are limited in the retrieved 2023–2024 oncology papers: the breast cancer paper treats FBXO6 primarily as a prognostic-model gene, and the HCC paper explicitly notes lack of mechanistic experimental verification for its proposed p53-ubiquitination framing. (fan2023developmentandvalidation pages 17-18, gong2024fbxofamilygenes pages 16-17)

Key primary sources used (publication date; URL)

  • Fujihira H, Asahina M, Suzuki T. Journal of Biochemistry (Sep 2022). https://doi.org/10.1093/jb/mvab101 (fujihira2022physiologicalimportanceof pages 9-10, fujihira2022physiologicalimportanceof pages 28-29)
  • Fan P et al. Frontiers in Oncology (May 2023). https://doi.org/10.3389/fonc.2023.1178595 (fan2023developmentandvalidation pages 1-2, fan2023developmentandvalidation pages 3-5, fan2023developmentandvalidation pages 17-18, fan2023developmentandvalidation pages 10-11)
  • Gong Q et al. Journal of Cancer Research and Clinical Oncology (Oct 2024). https://doi.org/10.1007/s00432-024-05948-3 (gong2024fbxofamilygenes pages 11-14, gong2024fbxofamilygenes pages 16-17)

References

  1. (fujihira2022physiologicalimportanceof pages 4-5): Haruhiko Fujihira, Makoto Asahina, and Tadashi Suzuki. Physiological importance of ngly1, as revealed by rodent model analyses. Journal of biochemistry, 171:161-167, Sep 2022. URL: https://doi.org/10.1093/jb/mvab101, doi:10.1093/jb/mvab101. This article has 25 citations and is from a peer-reviewed journal.

  2. (fujihira2022physiologicalimportanceof pages 9-10): Haruhiko Fujihira, Makoto Asahina, and Tadashi Suzuki. Physiological importance of ngly1, as revealed by rodent model analyses. Journal of biochemistry, 171:161-167, Sep 2022. URL: https://doi.org/10.1093/jb/mvab101, doi:10.1093/jb/mvab101. This article has 25 citations and is from a peer-reviewed journal.

  3. (fujihira2022physiologicalimportanceof pages 28-29): Haruhiko Fujihira, Makoto Asahina, and Tadashi Suzuki. Physiological importance of ngly1, as revealed by rodent model analyses. Journal of biochemistry, 171:161-167, Sep 2022. URL: https://doi.org/10.1093/jb/mvab101, doi:10.1093/jb/mvab101. This article has 25 citations and is from a peer-reviewed journal.

  4. (fan2023developmentandvalidation pages 1-2): Pengyu Fan, Jiajia Wang, Ruolei Li, Kexin Chang, Liuyin Liu, Yaping Wang, Zhe Wang, Bo Zhang, Cheng Ji, Jian Zhang, Suning Chen, and Rui Ling. Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer. Frontiers in Oncology, May 2023. URL: https://doi.org/10.3389/fonc.2023.1178595, doi:10.3389/fonc.2023.1178595. This article has 12 citations.

  5. (fan2023developmentandvalidation pages 3-5): Pengyu Fan, Jiajia Wang, Ruolei Li, Kexin Chang, Liuyin Liu, Yaping Wang, Zhe Wang, Bo Zhang, Cheng Ji, Jian Zhang, Suning Chen, and Rui Ling. Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer. Frontiers in Oncology, May 2023. URL: https://doi.org/10.3389/fonc.2023.1178595, doi:10.3389/fonc.2023.1178595. This article has 12 citations.

  6. (fan2023developmentandvalidation pages 17-18): Pengyu Fan, Jiajia Wang, Ruolei Li, Kexin Chang, Liuyin Liu, Yaping Wang, Zhe Wang, Bo Zhang, Cheng Ji, Jian Zhang, Suning Chen, and Rui Ling. Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer. Frontiers in Oncology, May 2023. URL: https://doi.org/10.3389/fonc.2023.1178595, doi:10.3389/fonc.2023.1178595. This article has 12 citations.

  7. (fan2023developmentandvalidation pages 10-11): Pengyu Fan, Jiajia Wang, Ruolei Li, Kexin Chang, Liuyin Liu, Yaping Wang, Zhe Wang, Bo Zhang, Cheng Ji, Jian Zhang, Suning Chen, and Rui Ling. Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer. Frontiers in Oncology, May 2023. URL: https://doi.org/10.3389/fonc.2023.1178595, doi:10.3389/fonc.2023.1178595. This article has 12 citations.

  8. (gong2024fbxofamilygenes pages 11-14): Qingge Gong, La Zhang, Jiao Guo, Wei Zhao, Baoyong Zhou, Changhong Yang, and Ning Jiang. Fbxo family genes promotes hepatocellular carcinoma via ubiquitination of p53. Journal of Cancer Research and Clinical Oncology, Oct 2024. URL: https://doi.org/10.1007/s00432-024-05948-3, doi:10.1007/s00432-024-05948-3. This article has 7 citations and is from a peer-reviewed journal.

  9. (gong2024fbxofamilygenes pages 7-11): Qingge Gong, La Zhang, Jiao Guo, Wei Zhao, Baoyong Zhou, Changhong Yang, and Ning Jiang. Fbxo family genes promotes hepatocellular carcinoma via ubiquitination of p53. Journal of Cancer Research and Clinical Oncology, Oct 2024. URL: https://doi.org/10.1007/s00432-024-05948-3, doi:10.1007/s00432-024-05948-3. This article has 7 citations and is from a peer-reviewed journal.

  10. (gong2024fbxofamilygenes pages 16-17): Qingge Gong, La Zhang, Jiao Guo, Wei Zhao, Baoyong Zhou, Changhong Yang, and Ning Jiang. Fbxo family genes promotes hepatocellular carcinoma via ubiquitination of p53. Journal of Cancer Research and Clinical Oncology, Oct 2024. URL: https://doi.org/10.1007/s00432-024-05948-3, doi:10.1007/s00432-024-05948-3. This article has 7 citations and is from a peer-reviewed journal.

  11. (gong2024fbxofamilygenes pages 2-4): Qingge Gong, La Zhang, Jiao Guo, Wei Zhao, Baoyong Zhou, Changhong Yang, and Ning Jiang. Fbxo family genes promotes hepatocellular carcinoma via ubiquitination of p53. Journal of Cancer Research and Clinical Oncology, Oct 2024. URL: https://doi.org/10.1007/s00432-024-05948-3, doi:10.1007/s00432-024-05948-3. This article has 7 citations and is from a peer-reviewed journal.

Artifacts

Citations

  1. fujihira2022physiologicalimportanceof pages 28-29
  2. fujihira2022physiologicalimportanceof pages 4-5
  3. fan2023developmentandvalidation pages 1-2
  4. fan2023developmentandvalidation pages 10-11
  5. gong2024fbxofamilygenes pages 11-14
  6. gong2024fbxofamilygenes pages 16-17
  7. fujihira2022physiologicalimportanceof pages 9-10
  8. fan2023developmentandvalidation pages 3-5
  9. fan2023developmentandvalidation pages 17-18
  10. gong2024fbxofamilygenes pages 7-11
  11. gong2024fbxofamilygenes pages 2-4
  12. https://doi.org/10.3389/fonc.2023.1178595
  13. https://doi.org/10.1007/s00432-024-05948-3
  14. https://doi.org/10.1093/jb/mvab101
  15. https://doi.org/10.1093/jb/mvab101,
  16. https://doi.org/10.3389/fonc.2023.1178595,
  17. https://doi.org/10.1007/s00432-024-05948-3,

πŸ“š Additional Documentation

Pn Notes

(FBXO6-pn-notes.md)

FBXO6 PN Consistency Notes

  • Generated: 2026-06-18
  • Project: PROTEOSTASIS
  • Scope: PN consistency rereview against local AIGR review and available deep-research artifacts
  • UniProt: Q9NRD1
  • AIGR review status: COMPLETE
  • Review batch: proteostasis-batch-2026-06-13
  • Batch change status: added

Source Files Checked

Deep Research Files

AIGR Review Snapshot

  • Description: FBXO6 (FBG2/FBS2, F-box protein that recognizes sugar chains 2) is a 293-amino-acid cytoplasmic F-box protein and a member of the FBA (F-box-associated) lectin family (FBXO2/FBXO6/FBXO17/FBXO27/FBXO44). It serves as the substrate-recognition subunit of SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complexes: its N-terminal F-box domain docks onto SKP1 (and thence CUL1-RBX1), while its C-terminal FBA/G domain is a carbohydrate-binding lectin module that recognizes N-linked glycans on client proteins. As an F-box protein FBXO6 has no intrinsic catalytic activity; catalysis is contributed by the RING subunit RBX1 within the assembled SCF complex, and FBXO6 confers substrate specificity. Through its FBA domain FBXO6 binds high-mannose oligosaccharides (with the chitobiose core being essential), complex-type glycans, and sulfated glycoproteins, and it preferentially engages denatured/misfolded glycoproteins. This lectin activity directs misfolded glycoproteins that have been retrotranslocated to the cytosol into the endoplasmic-reticulum-associated degradation (ERAD)/glycoprotein-quality-control pathway, promoting their ubiquitination and proteasomal degradation. FBXO6 also has a documented role in the DNA replication/damage checkpoint: it recognizes activated, S345-phosphorylated CHEK1 (CHK1) via its FBA domain and assembles an SCF(FBXO6) complex that ubiquitinates CHK1 and targets it for degradation, contributing to checkpoint termination and influencing cellular sensitivity to replication stress. FBXO6 is broadly but variably expressed (notably in liver and kidney) and interacts with VCP/p97. Among its glycoprotein clients, SCF(FBXO6/Fbs2) ubiquitinates the ER-membrane transcription factor NFE2L1/NRF1; in the absence of the cytoplasmic deglycosylase NGLY1, FBXO6-mediated ubiquitination of still-glycosylated NFE2L1 impairs its processing and nuclear function, blunting the proteasome "bounce-back" induction of new proteasome subunits, and genetic reduction of Fbs2/FBXO6 partially rescues Ngly1-knockout phenotypes in mice (with Fbs2-knockout mice otherwise healthy).
  • Existing/core annotation action counts: ACCEPT: 27; KEEP_AS_NON_CORE: 15; MARK_AS_OVER_ANNOTATED: 1

PN Consistency Summary

  • Consistency: Consistent. Falcon DR (NGLY1/NFE2L1 axis, proteasome bounce-back), review YAML, and the PN FBA F-box receptor placement converge. SPECIAL CASE confirmed: FBA lectin (GO:0030246, verified real) binding high-mannose/complex/sulfated glycans (chitobiose core essential, PMID:18203720), feeding glycoprotein-ERAD; plus a documented CHK1-degradation/checkpoint role (PMID:19716789, IDA).
  • PN story / NEW pressure: PN projects the generic GO:1990756 adaptor term (new_to_goa). Review's core MF is GO:0030246 carbohydrate binding (ACCEPT, already in GOA; experimentally grounded by PMID:18203720 glycan-array) β€” more informative than the generic adaptor. Catalytic GO:0061630 correctly held at contributes_to/non-core. The CHK1/DNA-damage-checkpoint role (GO:0000077) is a real second process kept non-core; review aptly MARK_AS_OVER_ANNOTATED for the GO:0006281 DNA repair term (FBXO6 terminates CHK1, is not a repair factor). Conclude: gene's distinctive lectin MF already captured; generic PN adaptor term not the best core.
  • Evidence alignment: PN reference only "15340381 / rev"; review uses gene-specific PMID:18203720 (HIGH/VERIFIED, lectin+SCF), PMID:19716789 (HIGH/VERIFIED, CHK1), PMID:34445249/ComplexPortal CPX-7905, plus Falcon DR (Fujihira/Suzuki NGLY1 review, NFE2L1). PN family review is a subset; good overlap on the SCF-receptor framing.
  • Verdict: Consistent; core MF correctly GO:0030246 (lectin, in GOA) over the generic PN adaptor term; CHK1 checkpoint role non-core; GO:0006281 over-annotation flagged. No over-reach.

Full Consistency Review

  • UniProt: Q9NRD1 (FBXO6/FBG2/Fbs2) Β· batch: proteostasis-batch-2026-06-13 (Falcon DR) Β· review status: COMPLETE
  • PN placement: UPS|E3 ubiquitin and UBL ligases|Cul1 substrate receptor|F-box|FBA ; PN-node mapping: group Cul1 substrate receptor=mapped/ok_for_propagationβ†’GO:1990756; F-box/FBA subtype+type=no_mapping; class=context_only/too_broadβ†’GO:0061630.
  • Consistency: Consistent. Falcon DR (NGLY1/NFE2L1 axis, proteasome bounce-back), review YAML, and the PN FBA F-box receptor placement converge. SPECIAL CASE confirmed: FBA lectin (GO:0030246, verified real) binding high-mannose/complex/sulfated glycans (chitobiose core essential, PMID:18203720), feeding glycoprotein-ERAD; plus a documented CHK1-degradation/checkpoint role (PMID:19716789, IDA).
  • PN story / NEW pressure: PN projects the generic GO:1990756 adaptor term (new_to_goa). Review's core MF is GO:0030246 carbohydrate binding (ACCEPT, already in GOA; experimentally grounded by PMID:18203720 glycan-array) β€” more informative than the generic adaptor. Catalytic GO:0061630 correctly held at contributes_to/non-core. The CHK1/DNA-damage-checkpoint role (GO:0000077) is a real second process kept non-core; review aptly MARK_AS_OVER_ANNOTATED for the GO:0006281 DNA repair term (FBXO6 terminates CHK1, is not a repair factor). Conclude: gene's distinctive lectin MF already captured; generic PN adaptor term not the best core.
  • Mapping strategy: Gene refines, does not change, the node β€” same as FBXO2. GO:1990756 group projection is the safe family MF; GO:0030246 is the more specific, already-in-GOA MF for the FBA-lectin subfamily. PN class GO:0061630 correctly too_broad.
  • Evidence alignment: PN reference only "15340381 / rev"; review uses gene-specific PMID:18203720 (HIGH/VERIFIED, lectin+SCF), PMID:19716789 (HIGH/VERIFIED, CHK1), PMID:34445249/ComplexPortal CPX-7905, plus Falcon DR (Fujihira/Suzuki NGLY1 review, NFE2L1). PN family review is a subset; good overlap on the SCF-receptor framing.
  • Verdict: Consistent; core MF correctly GO:0030246 (lectin, in GOA) over the generic PN adaptor term; CHK1 checkpoint role non-core; GO:0006281 over-annotation flagged. No over-reach.
  • Recommended edits: none to FBXO6-ai-review.yaml. [MAP] As for FBXO2, FBA-lectin subfamily nodes could carry GO:0030246 as the distinguishing MF in addition to GO:1990756.

PN Dossier Context

  • review_batch: proteostasis-batch-2026-06-13
  • review_yaml: genes/human/FBXO6/FBXO6-ai-review.yaml
  • PN workbook rows: 1

PN row 1: Ubiquitin Proteasome System | E3 ubiquitin and UBL ligases | Cul1 substrate receptor | F-box | FBA

  • UniProt: Q9NRD1
  • In branches: UPS
  • Signature domains: IPR001810
  • Auxiliary domains: IPR007397
  • PN references (titles):
    • 15340381 / rev
  • PN-node mapping records (path + ancestors):
    • [subtype] Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul1 substrate receptor|F-box|FBA
      status=no_mapping scope= GO=[]
      rationale: Reviewed as a narrower substrate-receptor, adaptor, domain, or family subdivision already covered by the curated parent adaptor/receptor mapping. No additional direct GO mapping is needed at this node.
    • [type] Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul1 substrate receptor|F-box
      status=no_mapping scope= GO=[]
      rationale: Reviewed as a narrower substrate-receptor, adaptor, domain, or family subdivision already covered by the curated parent adaptor/receptor mapping. No additional direct GO mapping is needed at this node.
    • [group] Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul1 substrate receptor
      status=mapped scope=ok_for_propagation_to_go GO=[GO:1990756 ubiquitin-like ligase-substrate adaptor activity]
      rationale: This PN group captures substrate receptors/adaptors for cullin/UBL ligase systems. The shared GO molecular-function target is ubiquitin-like ligase-substrate adaptor activity.
    • [class] Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases
      status=context_only scope=too_broad_to_propagate GO=[GO:0061630 ubiquitin protein ligase activity]
      rationale: This class is a genuine E3-ligase context, but its descendants include catalytic ligases, cullin scaffolds, substrate receptors, adaptors, cofactors, regulators, and UBL modifier systems. A class-level propagation would over-annotate.
    • [branch] Ubiquitin Proteasome System
      status=no_mapping scope= GO=[]
      rationale: Reviewed as the top-level UPS branch. It is a project taxonomy umbrella rather than a direct GO assertion; UPS propagation must come from manually curated child nodes.

Projected GO annotations (1)

  • GO:1990756 ubiquitin-like ligase-substrate adaptor activity | scope=ok_for_propagation_to_go | goa_status=new_to_goa | from=Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul1 substrate receptor

Note

This file is generated from the current PROTEOSTASIS phase-1 dossier and local gene-review artifacts. Edit the source review, PN mapping, or dossier rather than this generated note when correcting the underlying curation.

πŸ“„ View Raw YAML

id: Q9NRD1
gene_symbol: FBXO6
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  FBXO6 (FBG2/FBS2, F-box protein that recognizes sugar chains 2) is a 293-amino-acid
  cytoplasmic F-box protein and a member of the FBA (F-box-associated) lectin family
  (FBXO2/FBXO6/FBXO17/FBXO27/FBXO44). It serves as the substrate-recognition subunit
  of SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complexes: its N-terminal F-box domain
  docks onto SKP1 (and thence CUL1-RBX1), while its C-terminal FBA/G domain is a
  carbohydrate-binding lectin module that recognizes N-linked glycans on client
  proteins. As an F-box protein FBXO6 has no intrinsic catalytic activity; catalysis
  is contributed by the RING subunit RBX1 within the assembled SCF complex, and FBXO6
  confers substrate specificity. Through its FBA domain FBXO6 binds high-mannose
  oligosaccharides (with the chitobiose core being essential), complex-type glycans,
  and sulfated glycoproteins, and it preferentially engages denatured/misfolded
  glycoproteins. This lectin activity directs misfolded glycoproteins that have been
  retrotranslocated to the cytosol into the endoplasmic-reticulum-associated
  degradation (ERAD)/glycoprotein-quality-control pathway, promoting their
  ubiquitination and proteasomal degradation. FBXO6 also has a documented role in the
  DNA replication/damage checkpoint: it recognizes activated, S345-phosphorylated CHEK1
  (CHK1) via its FBA domain and assembles an SCF(FBXO6) complex that ubiquitinates CHK1
  and targets it for degradation, contributing to checkpoint termination and influencing
  cellular sensitivity to replication stress. FBXO6 is broadly but variably expressed
  (notably in liver and kidney) and interacts with VCP/p97. Among its glycoprotein
  clients, SCF(FBXO6/Fbs2) ubiquitinates the ER-membrane transcription factor
  NFE2L1/NRF1; in the absence of the cytoplasmic deglycosylase NGLY1, FBXO6-mediated
  ubiquitination of still-glycosylated NFE2L1 impairs its processing and nuclear
  function, blunting the proteasome "bounce-back" induction of new proteasome
  subunits, and genetic reduction of Fbs2/FBXO6 partially rescues Ngly1-knockout
  phenotypes in mice (with Fbs2-knockout mice otherwise healthy).
existing_annotations:
- term:
    id: GO:0036503
    label: ERAD pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: Phylogenetic assignment of involvement in ER-associated degradation, a core biological process of the FBA lectin family of F-box proteins.
    action: ACCEPT
    reason: Core biological process; FBXO6 recognizes glycans on misfolded glycoproteins to direct them to ERAD/proteasomal degradation, supported by UniProt and ISS.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: Involved in endoplasmic reticulum-associated degradation pathway (ERAD) for misfolded lumenal proteins by recognizing and binding sugar chains on unfolded glycoproteins that are retrotranslocated into the cytosol and promoting their ubiquitination and subsequent degradation
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: Phylogenetic assignment of cytoplasmic localization, consistent with the documented cytoplasmic site of FBXO6 action.
    action: ACCEPT
    reason: Correct localization; SCF(FBXO6) acts in the cytosol on retrotranslocated glycoproteins and on cytoplasmic CHK1; supported by IDA (PMID:19716789) and UniProt subcellular location.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0006516
    label: glycoprotein catabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: Phylogenetic assignment of involvement in glycoprotein catabolism, a core process for this lectin F-box family that targets glycoproteins for degradation.
    action: ACCEPT
    reason: Core biological process; FBXO6 recognizes glycans on misfolded glycoproteins and routes them to degradation.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: recognizing and binding sugar chains on unfolded glycoproteins that are retrotranslocated into the cytosol and promoting their ubiquitination and subsequent degradation
- term:
    id: GO:0019005
    label: SCF ubiquitin ligase complex
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: part_of
  review:
    summary: Phylogenetic assignment placing FBXO6 in the SCF (SKP1-CUL1-F-box) ubiquitin ligase complex, its defining structural context as an F-box protein.
    action: ACCEPT
    reason: Core cellular-complex assignment; FBXO6 assembles into a canonical SCF complex (SKP1, CUL1, RBX1) via its F-box domain, supported experimentally.
    supported_by:
    - reference_id: PMID:18203720
      supporting_text: All FBA family members co-immunoprecipitated components of the SCF complex
- term:
    id: GO:0031146
    label: SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: Phylogenetic assignment of involvement in SCF-dependent proteasomal degradation, the core biological process executed by SCF(FBXO6).
    action: ACCEPT
    reason: Core biological process; FBXO6 acts as the substrate receptor of an SCF complex that drives proteasomal degradation of its glycoprotein and CHK1 substrates.
    supported_by:
    - reference_id: PMID:19716789
      supporting_text: an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase, which mediates the ubiquitination and degradation of Chk1
- term:
    id: GO:0044322
    label: endoplasmic reticulum quality control compartment
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: Phylogenetic assignment to the ER quality-control compartment, inferred from the family's role in glycoprotein quality control/ERAD.
    action: KEEP_AS_NON_CORE
    reason: Plausible localization inferred from the ERAD/glycoprotein-QC role, but FBXO6 is a cytoplasmic protein that engages substrates after retrotranslocation; direct ERQC localization is not demonstrated for FBXO6.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: recognizing and binding sugar chains on unfolded glycoproteins that are retrotranslocated into the cytosol
- term:
    id: GO:0061630
    label: ubiquitin protein ligase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: contributes_to
  review:
    summary: Phylogenetic assignment of ubiquitin protein ligase activity with a contributes_to qualifier, reflecting that FBXO6 is the substrate receptor that contributes to the activity of the assembled SCF E3 ligase rather than carrying catalytic activity itself.
    action: KEEP_AS_NON_CORE
    reason: FBXO6 has no intrinsic catalytic ligase activity; catalysis resides in the RING subunit RBX1. The contributes_to qualifier is the correct way to capture that FBXO6 contributes substrate specificity to SCF ligase activity, but FBXO6's own core molecular function is carbohydrate binding, so this is retained as non-core rather than as the gene's primary function.
    supported_by:
    - reference_id: PMID:18203720
      supporting_text: As the substrate recognition subunits of multiprotein ubiquitin ligase complexes, F-box proteins have no intrinsic catalytic activity of their own.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: Combined automated electronic assignment of cytoplasmic localization, consistent with the experimentally documented cytoplasmic site of FBXO6.
    action: ACCEPT
    reason: Correct localization; redundant with the IDA (PMID:19716789) and IBA cytoplasm annotations.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:23108047
  qualifier: enables
  review:
    summary: IntAct interaction with CUL1 (Q13616), the cullin scaffold of the SCF complex. A real and functionally relevant interaction, but the bare protein binding term is uninformative.
    action: KEEP_AS_NON_CORE
    reason: Records the FBXO6-CUL1 SCF-assembly interaction, but bare protein binding is uninformative per curation guidelines; the SCF-complex membership is captured by GO:0019005.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'Q9NRD1; Q13616: CUL1; NbExp=6; IntAct=EBI-3938499, EBI-359390'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:27705803
  qualifier: enables
  review:
    summary: IntAct interaction with SKP1 (P63208), the adaptor that bridges the F-box domain to CUL1. A real SCF-assembly interaction, but bare protein binding is uninformative.
    action: KEEP_AS_NON_CORE
    reason: Records the FBXO6-SKP1 interaction central to SCF assembly, but bare protein binding is uninformative; SCF membership is captured by GO:0019005.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'Q9NRD1; P63208: SKP1; NbExp=10; IntAct=EBI-3938499, EBI-307486'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  qualifier: enables
  review:
    summary: High-throughput interactome interaction with CUL1 (Q13616). A real SCF-component interaction, but bare protein binding is uninformative.
    action: KEEP_AS_NON_CORE
    reason: Records the FBXO6-CUL1 interaction but bare protein binding is uninformative; captured at the complex level by GO:0019005.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'Q9NRD1; Q13616: CUL1; NbExp=6; IntAct=EBI-3938499, EBI-359390'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:30833792
  qualifier: enables
  review:
    summary: Interferon-stimulated-gene interactome capturing FBXO6 interactions with SKP1 (P63208), CUL1 (Q13616) and LGALS3BP (Q08380, a secreted glycoprotein). Bare protein binding is uninformative.
    action: KEEP_AS_NON_CORE
    reason: Records SCF-component interactions plus a glycoprotein (LGALS3BP) interaction, but bare protein binding is uninformative; relevant functions are captured by the SCF-complex and carbohydrate-binding annotations.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'Q9NRD1; Q08380: LGALS3BP; NbExp=2; IntAct=EBI-3938499, EBI-354956'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  qualifier: enables
  review:
    summary: Binary interactome reference map capturing the FBXO6-SKP1 (P63208) interaction. Bare protein binding is uninformative.
    action: KEEP_AS_NON_CORE
    reason: Records the FBXO6-SKP1 interaction but bare protein binding is uninformative; SCF membership is captured by GO:0019005.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'Q9NRD1; P63208: SKP1; NbExp=10; IntAct=EBI-3938499, EBI-307486'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: Cell-specific interactome capturing FBXO6 interactions with SKP1 (P63208) and CUL1 (Q13616). Bare protein binding is uninformative.
    action: KEEP_AS_NON_CORE
    reason: Records SCF-component interactions but bare protein binding is uninformative; captured at the complex level by GO:0019005.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'Q9NRD1; P63208: SKP1; NbExp=10; IntAct=EBI-3938499, EBI-307486'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:40205054
  qualifier: enables
  review:
    summary: Multimodal cell-map interactome capturing FBXO6 interactions with SKP1 (P63208) and CUL1 (Q13616). Bare protein binding is uninformative.
    action: KEEP_AS_NON_CORE
    reason: Records SCF-component interactions but bare protein binding is uninformative; captured at the complex level by GO:0019005.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'Q9NRD1; Q13616: CUL1; NbExp=6; IntAct=EBI-3938499, EBI-359390'
- term:
    id: GO:0006511
    label: ubiquitin-dependent protein catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Ortholog-based electronic assignment of ubiquitin-dependent protein catabolism, a parent process consistent with FBXO6's role as an SCF substrate receptor.
    action: ACCEPT
    reason: Correct but generic; the more specific GO:0031146 (SCF-dependent proteasomal ubiquitin-dependent catabolism) and GO:0036503 (ERAD) better capture the core role.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: promoting their ubiquitination and subsequent degradation
- term:
    id: GO:0019005
    label: SCF ubiquitin ligase complex
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: part_of
  review:
    summary: Ortholog-based electronic assignment of SCF complex membership, the defining context of FBXO6 as an F-box protein.
    action: ACCEPT
    reason: Core cellular-complex assignment; redundant with the IBA, NAS and IDA SCF-complex annotations and experimentally supported.
    supported_by:
    - reference_id: PMID:18203720
      supporting_text: All FBA family members co-immunoprecipitated components of the SCF complex
- term:
    id: GO:0030246
    label: carbohydrate binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: enables
  review:
    summary: Ortholog-based electronic assignment of carbohydrate binding, capturing the FBA/G-domain lectin activity that is the core molecular function distinguishing this F-box subfamily.
    action: ACCEPT
    reason: Core molecular function; the FBA domain is a lectin that binds high-mannose, complex and sulfated glycans, directly demonstrated by glycan-array and pulldown assays.
    supported_by:
    - reference_id: PMID:18203720
      supporting_text: FBXO6 bound high mannose glycans with relatively high affinity
- term:
    id: GO:0031146
    label: SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Ortholog-based electronic assignment of SCF-dependent proteasomal degradation, the core process executed by SCF(FBXO6).
    action: ACCEPT
    reason: Core biological process; redundant with the IBA, NAS and IDA annotations of the same term.
    supported_by:
    - reference_id: PMID:19716789
      supporting_text: an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase, which mediates the ubiquitination and degradation of Chk1
- term:
    id: GO:0036503
    label: ERAD pathway
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Ortholog-based electronic assignment of involvement in ERAD, a core biological process for FBXO6.
    action: ACCEPT
    reason: Core biological process; redundant with the IBA and ISS ERAD annotations.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: Involved in endoplasmic reticulum-associated degradation pathway (ERAD) for misfolded lumenal proteins
- term:
    id: GO:0044322
    label: endoplasmic reticulum quality control compartment
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: located_in
  review:
    summary: Ortholog-based electronic assignment to the ER quality-control compartment, inferred from the glycoprotein-QC/ERAD role.
    action: KEEP_AS_NON_CORE
    reason: Plausible but not directly demonstrated for FBXO6, which is a cytoplasmic protein engaging substrates after retrotranslocation; the experimentally supported localization is cytoplasm.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0061630
    label: ubiquitin protein ligase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: contributes_to
  review:
    summary: Ortholog-based electronic assignment of ubiquitin protein ligase activity with a contributes_to qualifier, reflecting FBXO6's contribution of substrate specificity to the SCF E3 ligase.
    action: KEEP_AS_NON_CORE
    reason: FBXO6 has no intrinsic catalytic ligase activity (RBX1 is catalytic); the contributes_to qualifier correctly conveys that FBXO6 contributes substrate recognition to SCF ligase activity, but the gene's own core molecular function is carbohydrate binding.
    supported_by:
    - reference_id: PMID:18203720
      supporting_text: As the substrate recognition subunits of multiprotein ubiquitin ligase complexes, F-box proteins have no intrinsic catalytic activity of their own.
- term:
    id: GO:0016567
    label: protein ubiquitination
  evidence_type: IEA
  original_reference_id: GO_REF:0000041
  qualifier: involved_in
  review:
    summary: UniPathway-derived general protein ubiquitination process, a parent of the specific SCF-dependent ubiquitination FBXO6 contributes to.
    action: KEEP_AS_NON_CORE
    reason: Correct but generic; the specific SCF-dependent proteasomal catabolism and ERAD annotations better capture FBXO6's role.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'PATHWAY: Protein modification; protein ubiquitination.'
- term:
    id: GO:0019005
    label: SCF ubiquitin ligase complex
  evidence_type: NAS
  original_reference_id: PMID:34445249
  qualifier: part_of
  review:
    summary: ComplexPortal/Reactome non-traceable author statement placing FBXO6 in an SCF E3 ubiquitin ligase complex; consistent with a defined ComplexPortal entry (CPX-7905, SCF FBXO6 variant).
    action: ACCEPT
    reason: Core cellular-complex assignment; FBXO6 is a defined F-box substrate-receptor variant of the SCF complex, supported experimentally (PMID:18203720) and by ComplexPortal CPX-7905.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: ComplexPortal; CPX-7905; SCF E3 ubiquitin ligase complex, FBXO6 variant.
- term:
    id: GO:0031146
    label: SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
  evidence_type: NAS
  original_reference_id: PMID:34445249
  qualifier: involved_in
  review:
    summary: ComplexPortal non-traceable author statement of involvement in SCF-dependent proteasomal degradation, the core process of SCF complexes including SCF(FBXO6).
    action: ACCEPT
    reason: Core biological process; redundant with the IBA, IEA and IDA annotations of the same term.
    supported_by:
    - reference_id: PMID:34445249
      supporting_text: SCF E3 ubiquitin ligase complexes that primarily modify protein substrates with poly-ubiquitin chains to target them for proteasomal degradation
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952618
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization within a CRL1/neddylation reaction (NEDD8 transfer to CRL1). Consistent with the cytoplasmic localization of FBXO6 and its SCF complex.
    action: ACCEPT
    reason: Correct localization; the cytosol is a child of cytoplasm and consistent with the experimentally supported cytoplasmic localization; these Reactome cytosol annotations reflect generic CRL/neddylation machinery reactions.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952620
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization within a CRL1/neddylation reaction. Consistent with FBXO6's cytoplasmic localization.
    action: ACCEPT
    reason: Correct localization (cytosol is part of cytoplasm); reflects generic CRL/neddylation reactions and is redundant with the experimentally supported cytoplasm annotation.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8955241
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization (CAND1 binds cytosolic CRL E3 ligases). Consistent with FBXO6's cytoplasmic localization.
    action: ACCEPT
    reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic CRL-regulation machinery reactions.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8955289
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization (COMMDs displace CAND1 from cytosolic CRL complexes). Consistent with FBXO6's cytoplasmic localization.
    action: ACCEPT
    reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic CRL-regulation machinery reactions.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8956040
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization (COP9 signalosome deneddylates cytosolic CRL complexes). Consistent with FBXO6's cytoplasmic localization.
    action: ACCEPT
    reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic CRL-regulation machinery reactions.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8956200
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization (MyrG-DCUN1D3 binds CRL1 complex). Consistent with FBXO6's cytoplasmic localization.
    action: ACCEPT
    reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic CRL-regulation machinery reactions.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-983140
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization within a generic ubiquitination reaction (transfer of Ub from E2 to substrate). Consistent with FBXO6's cytoplasmic localization.
    action: ACCEPT
    reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic SCF ubiquitination-reaction machinery.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-983147
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization within a generic ubiquitination reaction (release of E3 from polyubiquitinated substrate). Consistent with FBXO6's cytoplasmic localization.
    action: ACCEPT
    reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic SCF ubiquitination-reaction machinery.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-983156
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization within a generic ubiquitination reaction (polyubiquitination of substrate). Consistent with FBXO6's cytoplasmic localization.
    action: ACCEPT
    reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic SCF ubiquitination-reaction machinery.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-983157
  qualifier: located_in
  review:
    summary: Reactome curation of cytosolic localization within a generic ubiquitination reaction (interaction of E3 with substrate and E2-Ub complex). Consistent with FBXO6's cytoplasmic localization.
    action: ACCEPT
    reason: Correct localization; redundant with the experimentally supported cytoplasm annotation; reflects generic SCF ubiquitination-reaction machinery.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19716789}'
- term:
    id: GO:0000077
    label: DNA damage checkpoint signaling
  evidence_type: TAS
  original_reference_id: PMID:19716789
  qualifier: involved_in
  review:
    summary: Traceable author statement linking FBXO6 to the DNA damage/replication checkpoint via SCF(FBXO6)-mediated ubiquitination and degradation of activated CHK1, which terminates the checkpoint.
    action: KEEP_AS_NON_CORE
    reason: Well-supported, genuine role (degradation of activated CHK1 contributes to checkpoint termination), but distinct from the gene's primary glycan-recognition/ERAD core function; retained as a non-core second process.
    supported_by:
    - reference_id: PMID:19716789
      supporting_text: DNA damage not only activates Chk1, but also exposes a degron-like region at the carboxyl terminus of Chk1 to an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase, which mediates the ubiquitination and degradation of Chk1 and, in turn, terminates the checkpoint
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19716789
  qualifier: enables
  review:
    summary: IPI interaction with CHEK1/CHK1 (O14757), a functionally important FBXO6 substrate engaged via the FBA domain. Bare protein binding is uninformative.
    action: KEEP_AS_NON_CORE
    reason: Records the functionally meaningful FBXO6-CHK1 substrate interaction, but bare protein binding is uninformative; the CHK1-regulation role is captured by the checkpoint/SCF-catabolism annotations.
    supported_by:
    - reference_id: PMID:19716789
      supporting_text: endogenous Fbx6 was co-immunoprecipitated with Chk1 in extracts from non-transfected cells
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:19716789
  qualifier: located_in
  review:
    summary: Direct experimental evidence (immunolocalization) that FBXO6 is mainly localized to the cytoplasm, where it engages CHK1.
    action: ACCEPT
    reason: Core localization with direct experimental support; FBXO6 acts in the cytoplasm/cytosol on its substrates.
    supported_by:
    - reference_id: PMID:19716789
      supporting_text: The Fbx6-Chk1 interaction was only detected in the cytoplasmic compartment where Fbx6 is mainly localized
- term:
    id: GO:0006281
    label: DNA repair
  evidence_type: TAS
  original_reference_id: PMID:19716789
  qualifier: involved_in
  review:
    summary: Traceable author statement annotating FBXO6 to DNA repair, derived from its role in the ATR-CHK1 replication-checkpoint pathway that coordinates DNA damage/repair responses.
    action: MARK_AS_OVER_ANNOTATED
    reason: FBXO6's documented role is checkpoint termination via CHK1 degradation, not DNA repair per se; CHK1 activation triggers repair responses, but FBXO6 acts to remove activated CHK1 and is not itself a repair factor. DNA damage checkpoint signaling (GO:0000077) more accurately captures the role; DNA repair is an over-annotation of the downstream pathway.
    supported_by:
    - reference_id: PMID:19716789
      supporting_text: which mediates the ubiquitination and degradation of Chk1 and, in turn, terminates the checkpoint
- term:
    id: GO:0019005
    label: SCF ubiquitin ligase complex
  evidence_type: IDA
  original_reference_id: PMID:19716789
  qualifier: part_of
  review:
    summary: Direct experimental evidence that FBXO6 forms an SCF (SKP1-CUL1-FBXO6) complex, demonstrated by co-immunoprecipitation of SCF components.
    action: ACCEPT
    reason: Core cellular-complex assignment with direct experimental support.
    supported_by:
    - reference_id: PMID:19716789
      supporting_text: an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase
- term:
    id: GO:0031146
    label: SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
  evidence_type: IDA
  original_reference_id: PMID:19716789
  qualifier: involved_in
  review:
    summary: Direct experimental evidence that SCF(FBXO6) drives the ubiquitination and proteasomal degradation of CHK1, demonstrating involvement in SCF-dependent proteasomal catabolism.
    action: ACCEPT
    reason: Core biological process with direct experimental (IDA) support; FBXO6 FL supported CHK1 ubiquitination in vitro and FBXO6 depletion stabilized CHK1.
    supported_by:
    - reference_id: PMID:19716789
      supporting_text: only the Fbx6 FL protein supported ubiquitination of Chk1 in vitro
- term:
    id: GO:0036503
    label: ERAD pathway
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: involved_in
  review:
    summary: Sequence-similarity-based assignment of involvement in ERAD, transferred from the mouse ortholog (Q9QZN4); a core biological process.
    action: ACCEPT
    reason: Core biological process; consistent with the IBA and IEA ERAD annotations and the documented glycan-recognition/glycoprotein-degradation function.
    supported_by:
    - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
      supporting_text: Involved in endoplasmic reticulum-associated degradation pathway (ERAD) for misfolded lumenal proteins
- term:
    id: GO:0006508
    label: proteolysis
  evidence_type: TAS
  original_reference_id: PMID:10531035
  qualifier: involved_in
  review:
    summary: Early traceable author statement (F-box family identification paper) annotating FBXO6 to proteolysis, reflecting the general role of F-box proteins in SCF-mediated protein degradation.
    action: KEEP_AS_NON_CORE
    reason: Correct but very generic; the specific SCF-dependent proteasomal catabolism and ERAD annotations better capture FBXO6's role. The abstract describes the F-box family broadly rather than FBXO6 specifically.
    supported_by:
    - reference_id: PMID:10531035
      supporting_text: F-box proteins are one of the four subunits of ubiquitin protein ligases called SCFs
references:
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000041
  title: Gene Ontology annotation based on UniPathway vocabulary mapping
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10531035
  title: Identification of a family of human F-box proteins.
  findings:
  - statement: FBXO6 was identified as one of a family of 26 human F-box proteins; F-box proteins are substrate-recognition subunits of SCF ubiquitin ligases.
    reference_section_type: ABSTRACT
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Original identification of human FBXO6 (Fbx6) within the F-box family; abstract-only. Source of the generic proteolysis (TAS) annotation; describes the family rather than FBXO6-specific function.
- id: PMID:18203720
  title: Diversity in tissue expression, substrate binding, and SCF complex formation
    for a lectin family of ubiquitin ligases.
  findings:
  - statement: FBXO6 is a member of the FBA lectin family whose conserved G/FBA domain binds high-mannose, complex and sulfated glycans (chitobiose core essential); a Y241/W242 hydrophobic pocket is required for glycan binding, and FBXO6 co-precipitates SCF components (SKP1, CUL1, RBX1). F-box proteins have no intrinsic catalytic activity.
    reference_section_type: RESULTS
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Full text available; directly establishes FBXO6's lectin (carbohydrate-binding) molecular function, SCF complex formation, and the absence of intrinsic F-box catalytic activity. Primary support for the carbohydrate-binding and SCF-complex annotations.
- id: PMID:19716789
  title: The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity
    to replication stress.
  findings:
  - statement: FBXO6 (Fbx6) is the substrate-recognition subunit of an SCF (SKP1-CUL1-FBXO6) E3 ligase that, via its FBA domain, binds activated CHK1 and mediates CHK1 ubiquitination and degradation to terminate the replication checkpoint; FBXO6 is mainly cytoplasmic and its level inversely correlates with CHK1 and modulates camptothecin sensitivity.
    reference_section_type: RESULTS
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Full text available; sole experimental source for the CHK1-regulation/DNA-damage-checkpoint role, SCF(FBXO6) complex (IDA), cytoplasm (IDA), and SCF-dependent catabolism (IDA) annotations.
- id: PMID:23108047
  title: FBXW7-mediated degradation of CCDC6 is impaired by ATM during DNA damage
    response in lung cancer cells.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: Source of an IntAct FBXO6-CUL1 interaction (bare protein binding); abstract is centered on FBXW7/CCDC6, the FBXO6-CUL1 binding datum derives from the associated interaction dataset.
- id: PMID:27705803
  title: A High-Density Map for Navigating the Human Polycomb Complexome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: High-throughput interactome; source of an FBXO6-SKP1 bare protein binding annotation.
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: High-throughput interactome; source of an FBXO6-CUL1 bare protein binding annotation.
- id: PMID:30833792
  title: A protein-interaction network of interferon-stimulated genes extends the
    innate immune system landscape.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: ISG interactome; source of FBXO6 interactions with SKP1, CUL1 and the secreted glycoprotein LGALS3BP (bare protein binding).
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: Binary interactome reference map; source of an FBXO6-SKP1 bare protein binding annotation.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: Cell-specific interactome; source of FBXO6-SKP1/CUL1 bare protein binding annotations.
- id: PMID:34445249
  title: The SCF Complex Is Essential to Maintain Genome and Chromosome Stability.
  findings:
  - statement: The SCF complex comprises ~69 SCF E3 ubiquitin ligase complexes distinguished by variable F-box proteins that determine substrate specificity and target substrates for proteasomal degradation.
    reference_section_type: ABSTRACT
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Review (abstract-only in cache); used by ComplexPortal as NAS support for FBXO6 SCF-complex membership and SCF-dependent catabolism. Describes SCF complexes generally.
- id: PMID:40205054
  title: Multimodal cell maps as a foundation for structural and functional genomics.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: Multimodal cell-map interactome; source of FBXO6-SKP1/CUL1 bare protein binding annotations.
- id: Reactome:R-HSA-8952618
  title: AcM-UBE2M transfers NEDD8 to CRL1 E3 ubiquitin ligase complex
  findings: []
- id: Reactome:R-HSA-8952620
  title: NEDD8:AcM-UBE2M binds CRL1 E3 ubiquitin ligase complex
  findings: []
- id: Reactome:R-HSA-8955241
  title: CAND1 binds cytosolic CRL E3 ubiquitin ligases
  findings: []
- id: Reactome:R-HSA-8955289
  title: COMMDs displace CAND1 from cytosolic CRL E3 ubiquitin ligase complexes
  findings: []
- id: Reactome:R-HSA-8956040
  title: COP9 signalosome deneddylates cytosolic CRL E3 ubiquitin ligase complexes
  findings: []
- id: Reactome:R-HSA-8956200
  title: MyrG-DCUN1D3 binds CRL1 E3 ubiquitin ligase complex
  findings: []
- id: Reactome:R-HSA-983140
  title: Transfer of Ub from E2 to substrate and release of E2
  findings: []
- id: Reactome:R-HSA-983147
  title: Release of E3 from polyubiquitinated substrate
  findings: []
- id: Reactome:R-HSA-983156
  title: Polyubiquitination of substrate
  findings: []
- id: Reactome:R-HSA-983157
  title: Interaction of E3 with substrate and E2-Ub complex
  findings: []
- id: file:human/FBXO6/FBXO6-deep-research-falcon.md
  title: Falcon deep research report for human FBXO6
  findings:
  - statement: FBXO6 (FBS2) is the substrate-recognition module of an SCF-type (SCF^FBS2 / SCF^FBXO6) ubiquitin ligase that ubiquitinates N-glycoprotein substrates in protein quality control.
    supporting_text: FBXO6 (FBS2) is discussed as an F-box protein that serves as the substrate-recognition module of an SCF-type ubiquitin ligase (**SCF^FBS2 / SCF^FBXO6**), enabling ubiquitination of selected substrates, including **N-glycoproteins** involved in protein quality control.
  - statement: In the NGLY1/ERAD axis, SCF^FBS2 ubiquitinates ERAD glycoprotein substrates including the transcription factor NFE2L1/NRF1, which are then degraded by the proteasome after deglycosylation by NGLY1.
    supporting_text: ERAD glycoprotein substrates (including the transcription factor **NFE2L1/NRF1**) are ubiquitinated by multiple E3 ligases, including **SCF^FBS2**, and then degraded by the proteasome; in typical conditions, many ubiquitinated glycoproteins are thought to be **deglycosylated by NGLY1 during proteasomal degradation**.
  - statement: When NGLY1 is absent, SCF^FBS2-mediated ubiquitination of NFE2L1 impairs its processing/nuclear function and blocks induction of proteasome subunits (the proteasome bounce-back response), contributing to proteasome dysfunction.
    supporting_text: in the **absence of NGLY1**, SCF^FBS2-mediated ubiquitination of NFE2L1 is linked to impaired NFE2L1 processing/nuclear function and failure to induce proteasome subunits, contributing to chronic proteasome compromise and cytotoxicity.
  - statement: SCF^FBS2 acts in the cytosolic/proteasomal arm of ERAD after retrotranslocation; ubiquitinated N-glycoproteins accumulate in the cytosol when NGLY1 is absent.
    supporting_text: The mechanistic model places SCF^FBS2 activity in the **cytosolic/proteasomal degradation pathway for ERAD substrates** (i.e., after retrotranslocation from the ER lumen), and describes **accumulation of SCF^FBS2-ubiquitinated N-glycoproteins in the cytosol** when NGLY1 is absent.
  - statement: Genetic reduction of Fbs2/FBXO6 partially rescues Ngly1-knockout lethality in mice, and Fbs2-knockout mice are otherwise healthy, motivating FBS2 inhibition as a therapeutic concept for NGLY1 deficiency.
    supporting_text: genetic reduction of FBS2/FBXO6** can partially rescue lethality/phenotypes associated with **Ngly1 knockout**, and that **Fbs2 knockout mice are reported as healthy** in that review context.
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Falcon synthesis anchored on a peer-reviewed NGLY1 rodent-model review (Fujihira, Asahina & Suzuki, J Biochem 2022). Establishes a concrete PN-relevant glycoprotein substrate (NFE2L1/NRF1) and the NGLY1/proteasome-bounce-back link; cross-checked against the FBA-lectin/ERAD mechanism in UniProt and PMID:18203720. Cancer prognostic-signature claims (breast, HCC) are association-level and treated as leads only.
core_functions:
- description: Carbohydrate-binding (lectin) substrate-recognition subunit of an SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase; via its FBA/G domain FBXO6 binds N-linked high-mannose and complex/sulfated glycans on misfolded glycoproteins and, as part of the SCF complex, directs them to ubiquitination and proteasomal degradation in the glycoprotein-quality-control/ERAD pathway.
  molecular_function:
    id: GO:0030246
    label: carbohydrate binding
  locations:
  - id: GO:0005737
    label: cytoplasm
  supported_by:
  - reference_id: PMID:18203720
    supporting_text: FBXO6 bound high mannose glycans with relatively high affinity
  - reference_id: file:human/FBXO6/FBXO6-uniprot.txt
    supporting_text: recognizing and binding sugar chains on unfolded glycoproteins that are retrotranslocated into the cytosol and promoting their ubiquitination and subsequent degradation
  - reference_id: file:human/FBXO6/FBXO6-deep-research-falcon.md
    supporting_text: ERAD glycoprotein substrates (including the transcription factor **NFE2L1/NRF1**) are ubiquitinated by multiple E3 ligases, including **SCF^FBS2**, and then degraded by the proteasome; in typical conditions, many ubiquitinated glycoproteins are thought to be **deglycosylated by NGLY1 during proteasomal degradation**.
  directly_involved_in:
  - id: GO:0036503
    label: ERAD pathway
- description: Substrate receptor of an SCF(FBXO6) E3 ligase that recognizes activated, S345-phosphorylated CHEK1/CHK1 through its FBA domain and targets it for ubiquitination and proteasomal degradation, contributing to termination of the DNA replication/damage checkpoint and modulating cellular sensitivity to replication stress.
  molecular_function:
    id: GO:0030246
    label: carbohydrate binding
  locations:
  - id: GO:0005737
    label: cytoplasm
  supported_by:
  - reference_id: PMID:19716789
    supporting_text: an Fbx6-containing SCF (Skp1-Cul1-F box) E3 ligase, which mediates the ubiquitination and degradation of Chk1 and, in turn, terminates the checkpoint
  directly_involved_in:
  - id: GO:0000077
    label: DNA damage checkpoint signaling
proposed_new_terms: []
suggested_questions:
- question: Does FBXO6 recognize the CHK1 degron purely through a protein-protein (FBA-domain) interaction, or is glycan recognition also involved, and is the glycan-binding pocket (Y241/W242) dispensable for CHK1 targeting?
- question: What is the endogenous repertoire of glycoprotein substrates degraded specifically via SCF(FBXO6) (versus the paralog FBXO2), and how does FBXO6's broader specificity for complex and sulfated glycans translate into distinct in vivo substrates?
- question: How is partitioning between FBXO6's glycoprotein-ERAD role and its CHK1-checkpoint role regulated, and does the FBXO6-VCP/p97 interaction couple substrate recognition to retrotranslocation?
- question: Does SCF(FBXO6) ubiquitination of NFE2L1/NRF1 depend on the glycan-binding (FBA lectin) pocket, and is the proteasome bounce-back defect in NGLY1 deficiency driven specifically by FBXO6-mediated targeting of still-glycosylated NFE2L1?
suggested_experiments:
- description: Perform quantitative ubiquitinome/proteome profiling in FBXO6-knockout versus wild-type cells, with and without ER stress and replication stress (e.g. camptothecin), to define the endogenous SCF(FBXO6) substrate repertoire and distinguish glycoprotein from CHK1-dependent effects.
- description: Reconstitute SCF(FBXO6) ubiquitination in vitro with purified SKP1, CUL1, RBX1, an E2 and FBXO6, comparing wild-type FBXO6 with the Y241A/W242A glycan-pocket mutant against a high-mannose glycoprotein substrate and against phospho-CHK1 to dissect glycan-dependent versus glycan-independent substrate targeting.
- description: Use glycan-array and structural (crystallography/cryo-EM) analysis of the FBXO6 FBA domain bound to defined oligosaccharides to map the determinants of its broader specificity (high-mannose, complex, sulfated glycans) relative to FBXO2.